Published in Cancer Weekly, June 24th, 2003
"The purpose of this study was to examine whether exposure to magnetic fields (MFs) relevant for magnetic resonance imaging (MRI) in clinical routine influences cell cycle progression in two tumor cell lines in vitro," scientists in Germany report.
"HL60 and EA2 cells were exposed to four types of MFs:
(i) static MF of 1.5 and 7.05 T,
(ii) extremely low frequency magnetic gradient fields (ELFMGFs) with ± 10 mT/m and 100 Hz, as well as ±100 mT/m and 100 Hz,
(iii) pulsed high frequency MF in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.